Search
Close this search box.
on StartEngine
Health & WellnessTech
People of Color

PhorMed

Utilizing Gene Repair to Treat Diseases
Century City, 
CA
Investment type:
Equity
(Common Stock)
Target raise:
$10,000
 - $5,000,000
Minimum investment:​
$250
End date:
Oct 27, 2021
ended
PhorMed is a biopharmaceutical company leading the charge in the field of genomic medicine. We are working to utilize gene therapy to treat diseases, allowing the body to begin healing itself, and give new hope to patients suffering from diseases like AML, Hodgkin’s Lymphoma, Parkinson’s disease, and viruses.